<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11741">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02954094</url>
  </required_header>
  <id_info>
    <org_study_id>TARGET-HCC</org_study_id>
    <nct_id>NCT02954094</nct_id>
  </id_info>
  <brief_title>A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC</brief_title>
  <official_title>A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma (HCC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Target PharmaSolutions, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Target PharmaSolutions, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual
      clinical practice. TARGET-HCC will create a research registry of participants with HCC
      within academic and community real-world practices in order to assess the safety and
      effectiveness of the entire spectrum of current and future therapies across diverse
      populations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">October 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Establish a longitudinal observational cohort to understand the natural history and management of HCC, including the safety and outcomes of HCC treatment interventions utilized in usual clinical practice</measure>
    <time_frame>Up to 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the impact of HCC treatment interventions and concomitant medications on comorbid conditions and liver function</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate patient-reported outcomes measures during the natural course of HCC and management with HRQoL questionnaires</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Establish a Biorepository Specimen Bank (BSB)</measure>
    <time_frame>Up to 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Hepatocellular Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Patients enrolled in TARGET-HCC may be invited to participate in the Biorepository Specimen
      Bank (BSB). Blood samples and tissue samples for biomarker and DNA assays will be collected
      on a voluntary basis and participation in this project will not affect participation in the
      main study. These samples will be shipped to a central repository for storage to use in
      future studies. Samples stored at the biorepository will be identified only with the
      participant's unique study ID number and the date that the sample was obtained. This link
      between the participant's study ID number and their name will be available only at the site
      where the samples were obtained.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients being managed for HCC
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients, age â‰¥18 years

          2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC
             cholangiocarcinoma may be included; patients who are candidates for surgical and
             non-surgical treatment, as well as those being followed without specific HCC therapy
             may be included)

        Exclusion Criteria:

        1. Inability to provide written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shelby Gainer</last_name>
    <email>sgainer@targetpharmasolutions.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida Hepatology Research at CTRB</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610-0272</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Thyberg</last_name>
      <phone>352-273-7279</phone>
      <email>cynthia.thyberg@medicine.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Gastroenterology</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Jackman, PhD</last_name>
      <phone>904-633-0070</phone>
      <email>kelly.jackman@jax.ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schiff Center for Liver Diseases/University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffannia Grant</last_name>
      <phone>305-243-4649</phone>
      <email>t.grant11@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center, GI Research</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Thuluvath, M.D.</last_name>
      <phone>410-843-2075</phone>
      <email>thuluvath@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neehar Parikh, MD</last_name>
      <phone>877-758-2626</phone>
      <email>ndparikh@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Louis University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jo Ann Filla-Taylor, RN</last_name>
      <phone>314-977-7525</phone>
      <email>fillatj@slu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Scott</last_name>
      <phone>402-559-8588</phone>
      <email>rebbecca.scott.@unmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee T Blanchard, CCRC</last_name>
      <phone>919-843-5936</phone>
      <email>renee_blanchard@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center for Liver Disease and Transplant at CMC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gale Groseclose</last_name>
      <phone>704-355-4875</phone>
      <email>gale.groseclose@carolinashealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dina Pakstis</last_name>
      <phone>215-349-8548</phone>
      <email>Dina.Pakstis@uphad.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Beylotte, MS</last_name>
      <phone>843-876-4273</phone>
      <email>beylott@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Research Specialists of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilma Regalado</last_name>
      <phone>713-634-5110</phone>
      <email>wregalado@texasliver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bon Secours Liver Institute of Virginia</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Soublet, LPN</last_name>
      <phone>757-947-3190</phone>
      <email>joyce_soublet@bshsi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabella Bueno</last_name>
      <phone>206-744-3479</phone>
      <email>buenoi@medicine.washington.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 5, 2017</lastchanged_date>
  <firstreceived_date>November 1, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
